🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 23 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/11/2004 | 17,63 | 22,19 | 17,63 | 20,77 | +17,58% | 25,90% | 11.741.200 |
| 23/11/2004 | 17,79 | 17,86 | 17,55 | 17,67 | -0,67% | 1,74% | 1.622.000 |
| 22/11/2004 | 17,58 | 17,80 | 17,33 | 17,79 | +1,31% | 2,67% | 1.846.000 |
| 19/11/2004 | 18,20 | 18,41 | 17,50 | 17,56 | -3,33% | 5,00% | 1.586.400 |
| 18/11/2004 | 18,38 | 18,58 | 18,07 | 18,16 | -0,57% | 2,75% | 1.114.200 |
| 17/11/2004 | 18,45 | 18,70 | 18,08 | 18,27 | -0,92% | 3,33% | 657.600 |
| 16/11/2004 | 18,29 | 18,66 | 18,25 | 18,44 | +0,11% | 2,21% | 828.400 |
| 15/11/2004 | 18,56 | 18,57 | 18,22 | 18,42 | -0,38% | 1,86% | 937.400 |
| 12/11/2004 | 18,50 | 18,60 | 18,22 | 18,49 | -0,05% | 2,05% | 747.600 |
| 11/11/2004 | 18,15 | 19,02 | 18,01 | 18,50 | +1,62% | 5,57% | 1.854.000 |
| 10/11/2004 | 17,96 | 18,52 | 17,96 | 18,20 | +0,33% | 3,09% | 1.790.600 |
| 09/11/2004 | 17,81 | 18,34 | 17,78 | 18,14 | +1,62% | 3,17% | 1.558.400 |
| 08/11/2004 | 17,65 | 18,12 | 17,52 | 17,85 | +0,54% | 3,40% | 1.316.600 |
| 05/11/2004 | 17,43 | 17,88 | 17,41 | 17,76 | +1,92% | 2,70% | 1.508.400 |
| 04/11/2004 | 17,00 | 17,61 | 16,92 | 17,42 | +2,80% | 4,06% | 2.236.600 |
| 03/11/2004 | 16,33 | 17,23 | 16,26 | 16,95 | +8,17% | 5,94% | 4.373.000 |
| 02/11/2004 | 15,64 | 16,33 | 15,52 | 15,67 | +0,71% | 5,18% | 2.151.600 |
| 01/11/2004 | 15,69 | 15,95 | 15,45 | 15,56 | -0,48% | 3,22% | 897.400 |
| 29/10/2004 | 15,69 | 15,80 | 15,40 | 15,63 | -0,60% | 2,52% | 617.400 |
| 28/10/2004 | 15,75 | 15,79 | 15,44 | 15,73 | +0,32% | 2,22% | 1.059.000 |
| 27/10/2004 | 14,82 | 15,82 | 14,81 | 15,68 | +6,31% | 6,82% | 2.679.200 |
| 26/10/2004 | 14,75 | 15,17 | 14,14 | 14,75 | +1,69% | 6,99% | 2.384.800 |
| 25/10/2004 | 15,89 | 15,91 | 14,50 | 14,50 | -9,06% | 8,90% | 2.746.000 |
| 22/10/2004 | 16,21 | 16,21 | 15,91 | 15,95 | -1,67% | 1,88% | 621.000 |
| 21/10/2004 | 16,10 | 16,25 | 15,91 | 16,22 | -0,06% | 2,08% | 312.800 |
| 20/10/2004 | 15,99 | 16,27 | 15,95 | 16,23 | +1,28% | 2,00% | 295.200 |
| 19/10/2004 | 16,40 | 16,45 | 15,94 | 16,02 | -1,99% | 3,14% | 794.000 |
| 18/10/2004 | 16,50 | 16,58 | 16,25 | 16,35 | -2,24% | 1,97% | 1.021.200 |
| 15/10/2004 | 16,66 | 16,80 | 16,40 | 16,72 | +0,54% | 2,43% | 1.085.200 |
| 14/10/2004 | 16,71 | 16,80 | 16,47 | 16,63 | +0,48% | 1,94% | 639.800 |